Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06413979 · ClinicalTrials.gov registry record · NA

Family Support Protocol for Adolescent Internalizing Disorders

A NA study of Substance Use Disorders and Internalizing Disorders, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
4
Study locations

NCT06413979 is a NA study of Substance Use Disorders and Internalizing Disorders that is actively recruiting participants, run by The National Center on Addiction and Substance Abuse at Columbia University. The registered enrollment target is 60 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06413979, a NA study of Substance Use Disorders and Internalizing Disorders, is actively recruiting participants, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
4
Study locations

Study Summary

This R34 will develop and test an adjunctive treatment protocol for addressing co-occurring internalizing disorders among adolescents enrolled in usual care for substance use problems. Internalizing disorders (ID), primarily depression and anxiety, are highly prevalent among youth receiving community-based treatment for substance use disorder (SUD). Comorbidity rates range from 30-70% due to the multiple developmental pathways by which adolescent SUD and ID cause and exacerbate one another. Moreover, unresolved ID issues significantly interfere with youth SUD treatment and recovery processes. Yet, the youth SUD clinical workforce is not systematically educated or trained in evidence-based practices for ID; thus, line services for youth SUD do not systematically target ID. The research literature offers a few integrated behavioral models for simultaneously treating both SUD and ID in youth; however, such models feature intensive manualized procedures that have proven cumbersome to scale and deliver in frontline settings. As a result, the clinical workforce, though desiring ID-focused training, currently has inadequate resources for treating ID effectively. A promising solution to diminish this quality gap is developing an adjunctive, modular protocol to augment routine care for comorbid SUD/ID by directly targeting ID as a key treatment goal: Family Support Protocol for Adolescent Internalizing Disorders (Fam-AID). As an adjunctive protocol, Fam-AID will not require clinicians to markedly alter existing base practices for SUD. It will be anchored by three evidence-based foundations for treating co-occurring adolescent ID. First, it prioritizes family engagement in services and family-oriented treatment goals, which have been shown to enhance outcomes for youth SUD and ID alike. Second, it is a modular protocol that features core elements of manualized treatment for ID; core element interventions enhance treatment effectiveness by fostering implementation feasibility

Interventions

  • BEHAVIORAL Family Support Protocol for Adolescent Internalizing Disorders (Fam-AID)

Study Locations (4)

Florida

  • Gateway Community Services - Jacksonville

Illinois

  • Lurie Children's Hospital - Chicago

Indiana

  • Indiana University School of Medicine - Indianapolis

New York

  • Roberto Clemente Center - New York

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-07-29
Est. Completion 2027-03-31
Phase NA

What the Registry Record Tells You About NCT06413979

The ClinicalTrials.gov registry entry for NCT06413979 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (88% lower). The listed sponsor is The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Family Support Protocol for Adolescent Internalizing Disorders (Fam-AID) is the first listed.

NCT06413979 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Illinois, Indiana.

Frequently Asked Questions

What is clinical trial NCT06413979 about?

NCT06413979 is a clinical study titled "Family Support Protocol for Adolescent Internalizing Disorders". This R34 will develop and test an adjunctive treatment protocol for addressing co-occurring internalizing disorders among adolescents enrolled in usual care for substance use problems. Internalizing disorders (ID), primarily depression and anxiety, are highly prevalent among youth receiving communit...

What is the current status of trial NCT06413979?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-29. Estimated completion is 2027-03-31.

What conditions does trial NCT06413979 study?

This clinical trial studies the following conditions: Substance Use Disorders, Internalizing Disorders.

What interventions are being tested in trial NCT06413979?

The interventions under investigation include: Family Support Protocol for Adolescent Internalizing Disorders (Fam-AID) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06413979?

This trial is sponsored by The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06413979 being conducted?

This trial has 4 study locations across Florida, Illinois, Indiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.